Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo

Advanced Drug Delivery Reviews

Volumn 32, Issue 1-2, 1998, Pages 3-17

  Semple, Sean C ^a   Chonn, Arcadio ^a   Cullis, Pieter R ^a  

^a Inex Pharmaceuticals Corporation   (Canada)

Author keywords

Opsonins; Plasma proteins

Indexed keywords

BLOOD; CELL MEMBRANES; DRUG INTERACTIONS; LIPIDS; PROTEINS;

LIPOSOMES; OPSONINS;

CONTROLLED DRUG DELIVERY;

ALBUMIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; APOLIPOPROTEIN; BETA2 GLYCOPROTEIN 1; C REACTIVE PROTEIN; CARRIER PROTEIN; FIBRONECTIN; IMMUNOGLOBULIN; LIPID BINDING PROTEIN; LIPOSOME; RIBOZYME;

DRUG CLEARANCE; DRUG DELIVERY SYSTEM; OPSONIZATION; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RETICULOENDOTHELIAL SYSTEM; REVIEW;

EID: 0032496675     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00128-2     Document Type: Review

References (117)

1. Senior J. Fate and behavior of liposomes in vivo: A review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:1987;123-193.
2. Senior J., Gregoriadis G. Is half-life of circulating liposomes determined by changes in their permeability? FEBS Lett. 145:1982;109-115.
3. Needham D., McIntosh T.J., Lasic D.D. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim. Biophys. Acta. 1108:1992;40-48.
4. Black C.D.V., Gregoriadis G. Interaction of liposomes with blood plasma proteins. Biochem. Soc. Trans. 4:1976;253-256.
5. R.L. Juliano, G. Lin, The interaction of plasma proteins with liposomes: Protein binding and effects on the clotting and complement systems, in: H. Six, B. Tom (Eds.), Liposomes and Immunobiology, Elsevier, Amsterdam, 1980, pp. 49-56.
6. Bonte F., Juliano R.L. Interactions of liposomes with serum proteins. Chem. Phys. Lipids. 40:1986;359-372.
7. Chonn A., Semple S.C., Cullis P.R. Separation of large unilamellar liposomes from blood components by a spin column procedure: Towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim. Biophys. Acta. 1070:1991;215-222.
8. Chonn A., Semple S.C., Cullis P.R. Association of blood proteins with large unilamellar liposomes in vivo: Relation to circulation lifetimes. J. Biol. Chem. 267:1992;18759-18765.
9. Abra R.M., Hunt C.A. Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim. Biophys. Acta. 666:1981;493-499.
10. Senior J., Crawley J.C.W., Gregoriadis G. Tissue distribution of liposomes exhibiting half-lives in the circulation after in vivo injection. Biochim. Biophys. Acta. 839:1985;1-8.
11. Hope M.J., Bally M.B., Webb G., Cullis P.R. Production of large unilamellar vesicles by a rapid extrusion procedure: Characterization of size, trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta. 812:1985;55-65.
12. Lichtenberg D., Freire E., Schmidt C.F., Barenholz Y., Felgner P.L., Thompson T.E. Effect of surface curvature on stability, thermodynamic behavior, and osmotic activity of dipalmitoylphosphatidyl-choline single lamellar vesicles. Biochemistry. 20:1981;3426-3433.
13. Wong M., Anthony F.H., Tillack T.W., Thompson T.E. Fusion of dipalmitoylphosphatidylcholine vesicles at 4°C. Biochemistry. 21:1982;4126-4132.
14. Parente R.A., Lentz B.E. Phase behavior of large unilamellar vesicles composed of synthetic phospholipids. Biochemistry. 23:1984;2353-2359.
15. Scherphof G.L., Morselt H. On the size-dependent disintegration of small unilamellar phosphatidylcholine vesicles in rat plasma: Evidence of complete loss of vesicle structure. Biochem. J. 221:1984;423-429.
16. Aramaki Y., Murai M., Tsuchiya S. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes. Immunology. 80:1993;253-259.
17. T.A. Horbett, J.L. Brash, Proteins at Interfaces: Physicochemical and Biochemical Studies, American Chemical Society, Washington, DC, 1987.
18. Vroman L. Methods of investigating protein interactions on artificial and natural surfaces. Ann. New York Acad. Sci. 516:1987;300-307.
19. Senior J., Trimble K.R., Maskiewicz R. Interaction of positively-charged liposomes with blood: Implications for their application in vivo. Biochim. Biophys. Acta. 1070:1991;173-179.
20. Oku N., Tokudome Y., Namba Y., Saito N., Endo M., Hasegawa Y., Kawai M., Tsukada H., Okada S. Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomograpgy. Biochim. Biophys. Acta. 1280:1996;149-154.
21. Hernandez-Caselles T., Villalain J., Gomez-Fernandez J.C. Influence of liposome charge and composition on their interaction with human blood serum proteins. Mol. Cell. Biochem. 120:1993;119-126.
22. A. Chonn, S.C. Semple, P.R. Cullis, Protein-membrane interactions in the biological milieu, in: J.A.F. Op den Kamp (Ed.), Biological Membranes: Structure, Biogenesis and Dynamics, NATO ASI Series H: Cell Biology, 82, 1994, pp. 101-109.
23. van Oss C.J., Absolom D.R., Neumann A.W., Lingg W. Determination of the surface tension of proteins: Surface tension of native serum proteins in aqueous media. Biochim. Biophys. Acta. 670:1981;64-73.
24. Absolom D.R., van Oss C.J., Zingg W., Neumann A.W. Phagocytosis as a surface phenomenon: Opsonization by a specific adsorption of IgG as a function of bacteria hydrophobicity. J. Reticuloendothel. Soc. 31:1982;59-66.
25. Semple S.C., Chonn A., Cullis P.R. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry. 35:1995;2521-2525.
26. Moghimi S.M., Patel H.M. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Lett. 233:1988;143-150.
27. Moghimi S.M., Patel H.M. Differential properties of organ-specific serum opsonins for liver and spleen macrophages. Biochim. Biophys. Acta. 984:1989;379-386.
28. Moghimi S.M., Patel H.M. Serum opsonins and phagocytosis of saturated and unsaturated phopholipid liposomes. Biochim. Biophys. Acta. 984:1989;384-387.
29. Moghimi S.M., Patel H.M. Calcium as a possible modulator of Kupffer cell phagocytic function by regulating liver-specific opsoninc activity. Biochim. Biophys. Acta. 1028:1990;304-311.
30. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:1990;235-237.
31. Allen T.M., Hancen C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta. 1066:1991;29-36.
32. M1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett. 284:1991;263-266.
33. Maruyama K., Yuda T., Ishikura C., Kojima S., Iwatsuru M. Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes. Chem. Pharm. Bull. 39:1991;1620-1628.
34. Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta. 1062:1991;77-82.
35. Litzinger D.C., Buiting A.M.J., van Rooijen N., Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta. 1190:1994;99-107.
36. M1 and hydrophilic polymers increase liposome circulation times by inhibiting the association of blood proteins. J. Liposome Res. 2:1992;397-410.
37. Wassef N., Alving C.R. Complement-dependent phagocytosis of liposomes. Chem. Phys. Lipids. 64:1993;239-246.
38. M1 on liposome circulation time: Evidence supporting the dysopsonin hypothesis. Biochim. Biophys. Acta. 1166:1993;105-114.
39. Wassef N.M., Matyas G.R., Alving C.R. Complement-dependent phagocytosis of liposomes by macrophages: Suppressive effects of stealth lipids. Biochem. Biophys. Res. Commun. 176:1991;866-873.
40. Oja C.D., Semple S.C., Chonn A., Cullis P.R. Influence of dose on liposome clearance: Critical role of blood proteins. Biochim. Biophys. Acta. 1281:1996;31-37.
41. Chonn A., Cullis P.R., Devine D.V. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146:1991;4234-4241.
42. Kiwada H., Obara S., Nishiwaki H., Kato Y. Studies on the uptake mechanism of liposomes by perfused rat liver. I. An investigation of effluent profiles with perfusate containing no blood component. Chem. Pharm. Bull. 34:1986;1249-1255.
43. Kiwada H., Miyajima T., Kato Y. Studies on the uptake mechanism of liposomes by perfused rat liver. II. An indispensable factor for liver uptake in serum. Chem. Pharm. Bull. 35:1987;1189-1196.
44. Nishikawa K., Arai H., Inoue K. Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J. Biol. Chem. 265:1990;5226-5234.
45. Lee K-D., Pitas R.E., Papahadjopoulos D. Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells. Biochim. Biophys. Acta. 1111:1992;1-10.
46. G. Gregoriadis, Fate of injected liposomes: Observations on entrapped solute retention, vesicle clearance and tissue distribution in vivo, in: G. Gregoriadis (Ed.), Liposomes as Drug Carriers: Recent Trends and Progress, Wiley, New York, 1988, pp. 3-11.
47. K.J. Hwang, P.L. Beaumier, Disposition of liposomes in vivo, in: G. Gregoriadis (Ed.), Liposomes as Drug Carriers: Recent Trends and Progress, Wiley, New York, 1988, pp. 19-27.
48. Tall A.R., Green P.H.R. Incorporation of phosphatidylcholine into spherical and discoidal lipoproteins during incubation of egg phosphatidylcholine vesicles with isolated high density lipoproteins or with plasma. J. Biol. Chem. 256:1981;2035-2042.
49. Chobanian J.V., Tall A.R., Brecher P.I. Interaction between unilamellar egg yolk lecithin vesicles and human high density lipoprotein. Biochemistry. 18:1979;180-187.
50. Scherphof G., Roerdink F., Waite M., Parks J. Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. Biochim. Biophys. Acta. 542:1978;296-302.
51. Krupp L., Chobanian A.V., Brecher P.I. The in vivo transformation of phospholipid vesicles to a particle resembling HDL in the rat. Biochem. Biophys. Res. Commun. 72:1976;1251-1259.
52. Tall A.R. Studies on the transfer of phosphatidylcholine from unilamellar vesicles into plasma HDL in the rat. J. Lipid Res. 21:1980;354-360.
53. Shahrokh Z., Nichols A.V. Particle size interconversion of human low density lipoproteins during incubation of plasma with phosphatidylcholine vesicles. Biochem. Biophys. Res. Commun. 108:1982;888-895.
54. Senior J., Gregoriadis G. Role of lipoproteins in stability and clearance of liposomes administered to mice. Biochem. Soc. Trans. 12:1984;339-346.
55. Guo L.S.S., Hamilton R.L., Goerke J., Weinstein J.N., Havel R.J. Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. J. Lipid Res. 21:1980;993-1000.
56. Atkinson D., Smith H.M., Dickinson J., Austin J.P. Interaction of apoprotein from porcine high-density lipoprotein with dimyristoyl lecithin. I. The structure of the complexes. Eur. J. Biochem. 64:1976;541-548.
57. Forte T., Nichols A.V., Gong E.L., Lux S., Levy R.I. Electron microscopic study on reassembly of plasma high density apoprotein with various lipids. Biochim. Biophys. Acta. 248:1971;381-388.
58. Swaney J.B. Properties of lipid-apolipoprotein association products. Complexes of human apo A-I and binary phospholipid mixtures. J. Biol. Chem. 255:1980;8798-8805.
59. Swaney J.B. Mechanisms of protein-lipid interaction. Association of apolipoproteins A-I and A-II with binary phospholipid mixtures. J. Biol. Chem. 255:1980;8791-8797.
60. Tall A. Plasma lipid transfer proteins. J. Lipid Res. 27:1986;361-367.
61. Tall A.R., Abreu E., Shuman J. Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein. J. Biol. Chem. 258:1983;2174-2179.
62. Tall A.R., Forester L., Bongiovanni G. Facilitation of phosphatidylcholine transfer into high density lipoproteins by an apolipoprotein in the density 1.20-1.26 g/ml fraction of plasma. J. Lipid Res. 24:1983;277-283.
63. Muller-Eberhard H.J. The membrane attack complex of complement. Annu. Rev. Immunol. 4:1986;503-528.
64. Finkelstein M.C., Weissmann G. Enzyme replacement via liposomes: Variations in lipid composition determine liposomal integrity in biological fluids. Biochim. Biophys. Acta. 587:1979;202-216.
65. Haxby J.A., Gotze O., Muller-Eberhard H.J., Kinsky S.C. Release of trapped marker from liposomes by the action of purified complement components. Proc. Natl. Acad. Sci. USA. 64:1969;290-296.
66. Kinsky S.C., Haxby J.A., Zopf D.A., Alving C.R., Kinsky C.B. Complement-dependent damage to liposomes prepared from pure lipids and Forssman hapten. Biochemistry. 8:1969;4149-4156.
67. Kataoka T., Inoue K., Luderitz O., Kinsky S.C. Antibody- and complement-dependent damage to liposomes prepared with bacterial lipopolysaccharides. Eur. J. Biochem. 21:1971;80-87.
68. Inoue K., Kinoshita T., Okada M., Akiyama Y. Release of phospholipids from liposomal model membrane damaged by antibody and complement. J. Immunol. 119:1977;73-81.
69. Shin M.L., Paznekas W.A., Mayer M.M. On the mechanism of membrane damage by complement: The effect of length and unsaturation of the acyl chains in liposomal bilayers and the effect of cholesterol concentration in sheep erythrocyte and liposomal membranes. J. Immunol. 120:1978;1996-2002.
70. Kinoshita T., Inoue K., Okada M., Akiyama Y. Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli. J. Immunol. 119:1977;73-81.
71. Moghimi S.M., Muir I.S., Illum L., Davis S.S., Kolb-Bachofen V. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta. 1179:1993;157-164.
72. Absolom D.R. Opsonins and dysopsonins: An overview. Methods Enzymol. 132:1986;281-289.
73. Patel H.M. Influence of lipid composition on opsonophagocytosis of liposomes. Res. Immunol. 143:1992;242-249.
74. Patel H.M. Serum opsonins and liposomes: Their interaction and opsonophagocytosis. Crit. Rev. Ther. Drug Carrier Syst. 9:1992;39-46.
75. Roerdink F., Wassef N.M., Richardson E.C., Alving C.R. Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement. Biochim. Biophys. Acta. 734:1983;33-40.
76. Verma J.N., Wassef N.M., Wirtz R.A., Atkinson C.T., Aikawa M., Loomis L.D., Alving C.R. Phagocytosis of liposomes by macrophages: Intracellular fate of malaria antigen. Biochim. Biophys. Acta. 1066:1991;229-236.
77. Devine D.V., Wong K., Serrano K., Chonn A., Cullis P.R. Liposome-complement interactions in rat serum: Implications for liposome survival studies. Biochim. Biophys. Acta. 1191:1994;43-51.
78. Marjan J., Zongcen X., Devine D.V. Liposome-induced activation of the classical complement pathway does not require immunoglobulin. Biochim. Biophys. Acta. 1192:1994;35-42.
79. Thielens N.M., Colomb M.G. A model for the study of the assembly and regulation of human complement C3 convertase (classical pathway). Eur. J. Immunol. 16:1986;617-623.
80. Funato K., Yoda R., Kiwada H. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochim. Biophys. Acta. 1103:1991;198-205.
81. Mold C. Effect of membrane phospholipids on activation of the alternative complement pathway. J. Immunol. 143:1989;1663-1669.
82. Szebeni J., Wassef N.M., Spielberg H., Rudolph A.S., Alving C.R. Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: Evidence for anti-lipid antibodies and alternative pathway activation. Biochem. Biophys. Res. Commun. 205:1994;255-263.
83. Thiel S. Mannan-binding protein, a complement activating animal lectin. Immunopharmacology. 24:1992;91-98.
84. Kuhlman M., Joiner K., Ezekowitz R.A. The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169:1989;1733-1741.
85. J. Marjan, The interaction of liposomes with complement proteins and protein S, Ph.D. thesis, The University of British Columbia, 1994.
86. Derksen J.T.P., Morselt H.W.M., Kalicharan D., Hulstaert C.E., Scherphof G.L. Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro. Exp. Cell Res. 168:1987;105-112.
87. Hsu M.J., Juliano R.L. Interactions of liposomes with the reticuloendothelial system. II. Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim. Biophys. Acta. 720:1982;411-419.
88. Lewis J.T., Hafeman D.G., McConnell H.M. Kinetics of antibody-dependent binding of haptenated phospholipid vesicles to a macrophage-related cell line. Biochemistry. 19:1980;5376-5382.
89. Leserman L.D., Weinstein J.N., Blumenthal R., Terry W.D. Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells. Proc. Natl. Acad. Sci. USA. 77:1980;4089-4093.
90. Debs R.J., Heath T.D., Papahadjopoulos D. Targeting of anti-Thy 1.1 monoclonal antibody conjugated liposomes in Thy 1.1 mice after intravenous administration. Biochim. Biophys. Acta. 901:1987;183-191.
91. Torchilin V.P., Klibanov A.L., Huang L., O'Donnell S., Nossiff N.D., Khaw B.A. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. FASEB J. 6:1992;2716-2719.
92. Cheng H.M., Ngeow Y.F., Sam C.K. Heat inactivation of serum potentiates anti-cardiolpin antibody binding in ELISA. J. Immunol. Methods. 124:1989;235-241.
93. Lechner K., Pabinger-Fasching I. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis. 15:1987;254-260.
94. Alving C.R. Natural antibodies against phospholipids and liposomes in humans. Biochem. Soc. Trans. 12:1984;342-349.
95. Shapiro S.S., Thiagarajan P. Lupus anticoagulants. Prog. Hemostas. Thromb. 6:1982;263-270.
96. Rauch J., Tannenbaum M., Tannenbaum H., Ramelson H., Cullis P.R., Tilcock C.P.S., Hope M.J., Janoff A.S. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J. Biol. Chem. 261:1986;9672-9679.
97. Senior J., Waters J.A., Gregoriadis G. Antibody-coated liposomes: The role of non-specific antibody adsorption. FEBS Lett. 196:1986;54-58.
98. Brown E.J. The role of extracellular matrix proteins in the control of phagocytosis. J. Leukocyte Biol. 39:1986;579-586.
99. Ruoslahti E. Fibronectin and its receptors. Annu. Rev. Biochem. 57:1988;375-383.
100. Pommier C.G., Inada I., Fries L.F., Takahashi T., Frank M.M., Brown E.J. Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes. J. Exp. Med. 157:1983;1844-1851.
101. Williams K.J., Scanu A.M. Uptake of endogenous cholesterol by a synthetic lipoprotein. Biochim. Biophys. Acta. 875:1986;183-190.
102. Ivanov V.O., Preobrazhensky S.N., Tsibulsky V.P., Babaev V.R., Repin V.S., Smirnov V.N. Liposome uptake by cultured macrophages mediated by modified low-density lipoproteins. Biochim. Biophys. Acta. 846:1985;76-83.
103. Williams K.J., Tall A.R., Bisgaier C., Brocia R. Phospholipid liposomes acquire apolipoprotein E in atherogenic plasma and block cholesterol loading of cultured macrophages. J. Clin. Invest. 79:1987;1466-1472.
104. Williams K.J., Werth V.P., Wolff J.A. Intravenously administered lecithin liposomes: A synthetic antiatherogenic lipid particle. Perspect. Biol. Med. 27:1984;417-423.
105. Bisgaier C.L., Siebenkas M.V., Williams K.J. Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes. J. Biol. Chem. 264:1989;862-869.
106. Young B., Gleeson M., Cripps A.W. C-reactive protein: A critical review. Pathology. 23:1991;118-126.
107. Steel D.M., Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid a protein. Immunol. Today. 15:1994;81-89.
108. Volanakis J.E., Kaplan M.H. Interactions of C-reactive protein with the complement system. II. Consumption of guinea pig complement by CRP complexes: Requirement for human C1q. J. Immunol. 113:1974;9-16.
109. Kaplan M.H., Volanakis J.E. Interactions of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin, and sphingomyelin. J. Immunol. 112:1974;2135-2141.
110. Siegel J., Rent R., Gewurz G. Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera. J. Exp. Med. 140:1974;631-639.
111. Siegel J., Osmand A.P., Wilson M.F., Gewurz H. Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations. J. Exp. Med. 142:1975;709-711.
112. Osmand A.P., Mortensen R.F., Siegel J., Gewurz H. Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP. J. Exp. Med. 142:1975;1065-1072.
113. Richards R.L., Gewurz H., Osmand A.P., Alving C.R. Interactions of C-reactive protein and complement with liposomes. Proc. Natl. Acad. Sci. USA. 74:1977;5672-5680.
114. Volanakis J.E., Narkates A.J. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J. Immunol. 126:1981;1820-1827.
115. Barna B.P., Deodhar S.D., Gautam S., Yen-Lieberman B., Roberts D. Macrophage activation and generation of tumoricidal activity by liposome-associated human C-reactive protein. Cancer Res. 44:1984;305-312.
116. Chonn A., Semple S.C., Cullis P.R. β2-Glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a major role in the immune clearance of 'nonself' particles. J. Biol. Chem. 270:1995;25845-25849.
117. Liu F., Liu D. Serum independent liposome uptake by mouse liver. Biochim. Biophys. Acta. 1278:1996;5-11.